Renal-hepatic-pancreatic dysplasia is a rare genetic disorder that affects the development of the kidneys, liver, and pancreas in a fetus. It is also known as Ivemark syndrome or polysplenia syndrome. There are no known synonyms for this condition, as it is a unique medical term used specifically to describe this disorder. Symptoms of renal-hepatic-pancreatic dysplasia can vary widely but may include congenital heart defects, abnormal gastrointestinal structure, and recurrent infections. Treatment options are limited and may include surgery to correct any structural abnormalities or to remove affected organs. Overall, early diagnosis and a multidisciplinary approach are essential in managing this complex condition.